Read ePaper

Groundbreaking Study

50 Pounds Down! Zepbound Beats Wegovy In Groundbreaking Study

07 Dec 2024

Eli Lilly has announced promising results from its latest clinical trial, showing that Zepbound is more effective than Wegovy in maintaininglong-term weight loss. Based on the data from the SURMOUNT-5 clinical trial, Zepbound produced significantly greater weight loss compared to Wegovy, which makes it a potentially better treatment for obesity...

Groundbreaking Study Unveils Innovative Treatment For Neurological Diseases

18 Oct 2024

The causes of complex neurological disorders like Alzheimer's and multiple sclerosis remain a puzzle for scientists and doctors, making early diagnosis and effective treatment difficult. Even when identical twins share the same genetic risk factors, one may develop a neurological disorder while the other does not. This is because, unlike...